Kenneth A. Bauer

Active 1983–2025

82
Papers
21,614
Citations
67
h-index
80
i10-index

Citations

Citations per year for Kenneth A. Bauer1974: 1 citations1983: 2 citations1984: 6 citations1985: 6 citations1986: 8 citations1987: 10 citations1988: 10 citations1989: 14 citations1990: 14 citations1991: 20 citations1992: 14 citations1993: 20 citations1994: 20 citations1995: 35 citations1996: 34 citations1997: 56 citations1998: 50 citations1999: 77 citations2000: 67 citations2001: 66 citations2002: 88 citations2003: 131 citations2004: 119 citations2005: 92 citations2006: 106 citations2007: 111 citations2008: 110 citations2009: 111 citations2010: 144 citations2011: 124 citations2012: 127 citations2013: 117 citations2014: 80 citations2015: 83 citations2016: 65 citations2017: 55 citations2018: 35 citations2019: 249 citations2020: 593 citations2021: 913 citations2022: 533 citations2023: 266 citations2024: 362 citations2025: 109 citations2026: 7 citations1975–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,832 citing papers, 22.8% of this breakdownUnited Kingdom: 632 citing papers, 7.9% of this breakdownCanada: 524 citing papers, 6.5% of this breakdownItaly: 515 citing papers, 6.4% of this breakdownGermany: 485 citing papers, 6% of this breakdownNetherlands: 419 citing papers, 5.2% of this breakdownChina: 369 citing papers, 4.6% of this breakdownFrance: 333 citing papers, 4.2% of this breakdownSpain: 205 citing papers, 2.6% of this breakdownAustralia: 185 citing papers, 2.3% of this breakdownSwitzerland: 182 citing papers, 2.3% of this breakdownSweden: 156 citing papers, 1.9% of this breakdown
0%22.8%Other 27.3%

Fields

  • Medicine85.4%
  • Biochemistry, Genetics and Molecular Biology7.2%
  • Immunology and Microbiology2%
  • Neuroscience0.8%
  • Nursing0.7%
  • Engineering0.6%
  • Other3.3%

Topics

  • Venous Thromboembolism Diagnosis and Management11.9%
  • COVID-19 Clinical Research Studies6.9%
  • Blood Coagulation and Thrombosis Mechanisms6.8%
  • Atrial Fibrillation Management and Outcomes5.2%
  • Long-Term Effects of COVID-194.5%
  • SARS-CoV-2 and COVID-19 Research2.6%
  • Other62.1%

Coauthors

All papers

Open in search
  1. Extrapulmonary manifestations of COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2020 cited by 3,304

  2. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

    Authors: , , , , , , , , , , , , , , , , , , - Blood Advances 2018 cited by 812

  3. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 714

  4. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer

    Authors: , , , , , , , , , , , , , , , , - JCI Insight 2019 cited by 170

  5. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Blostein, Isabel Bogalho, Barbara Bournet, Patricia Casais, Alain Carpentier, Gabriela Cesarman‐Maus, Joydeep Chakbrabartty, Hugo Clemente, J. Connault, Ludovic Doucet, C. Durant, Joseph Emmerich, Anna Falanga, Clemens Feistritzer, Carme Font, Charles W. Francis, Enrique Gallardo, Thomas Gary, Jean‐Christophe Gris, Cecilia Guillermo, A. Hij, Russel Hull, Takayuki Ikezoe, Luis Jara‐Palomares, Nigel S. Key, Jamilya Khrizroeva, Maral Koolian, Florian Länger, C. Le Hello, Ramón Lecumberri, Lai Heng Lee, Howard A. Liebman, Luisa Lopes Dos Santos, Duarte Machado, Isabelle Madelaine, А. D. Makatsariya, Mario Mandalà, Anthony Marayevas, Zora Marjanovic, Christine Marosi, Ellis Martin, Luis Meillón, E. Messas, António Moreira, Ahmet Muzaffer Demir, Arlette Ndour, Michel N'Guessan, Remedios Otero, Vanessa Pachón Olmos, Ana Pais, Florian Posch, Matthias Preusser, H. Riess, Marc Righini, Cynthia Rothschild, André Roussin, José Antonio Rueda-Camino, Pedro Ruiz‐Artacho, Sanjith Saseedharan, Ali Shamseddine, Gerald A. Soff, Hans Stricker, Vicky Tagalakis, Alì Taher, Toussaint Toutou, Javier Trujillo‐Santos, Stéphane Villiers, Raymond Wong, Norizaku Yamada - The Lancet Oncology 2019 cited by 658

  6. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

    Authors: , , , , , , , - Journal of Thrombosis and Thrombolysis 2016 cited by 342

  7. Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J Pekkanen, Juha Pekkanen, Ralph B. D’Agostino, William B. Kannel, Peter W.F. Wilson, G. Tofler, Carmen Luisa Arocha-Piñango, Álvaro Rodríguez-Larralde, Eva Nagy, Michael R. Mijares, Raúl E. Espinosa, E Rodriquez-Roa, Elena Ryder, María Diez‐Ewald, G Campos, E Torres, Esther Torres, Roberto Marchioli, Franco Valagussa, Annika Rosengren, Lars Wilhelmsen, George Lappas, Henry Eriksson, Peter Cremer, D. Nagel, J. David Curb, Bryan S. Quintanilla Rodriguez, Katsuhiko Yano, Jukka T. Salonen, K. Nyyssönen, T-P Tuomainen, B Hedblad, Peter Lind, Hannelore Loewel, W Koenig, T W Meade, J Cooper, Bianca De Stavola, Christine Knottenbelt, George J. Miller, J Cooper, Kenneth A. Bauer, R D Rosenberg, Shinichi Sato, Akihiko Kitamura, Yoshihiko Naito, Timo Palosuo, Pierre Ducimetière, Philippe Amouyel, D Arveiler, A. E. Evans, Jean Ferrières, I. Juhan‐Vague, Anne Bingham, H Schulte, G. Aßmann, Bernard Cantin, Benoı̂t Lamarche, JP Després, Gilles R. Dagenais, H Tunstall-Pedoe, Mark Woodward, Yoav Ben‐Shlomo, George Davey Smith, Vittorio Palmieri, Jwu‐Lai Yeh, Alicja R. Rudnicka, Paul M. Ridker, Francesco Rodeghiero, Alberto Tosetto and 17 more - JAMA 2005 cited by 1,113

  8. Parenteral Anticoagulants

    Authors: , , , , , - CHEST Journal 2008 cited by 750

  9. Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood Advances 2020 cited by 58

  10. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

    Authors: , , , , , , , , , , , , - The Lancet 2009 cited by 979

  11. Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team

    Authors: , , , , , , , , , , , , , , , , , , , - The American Journal of Medicine 2020 cited by 67

  12. Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy

    Authors: , , , , , , - Clinical Cancer Research 2009 cited by 469

  13. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis

    Authors: , , , , , - BMJ 2012 cited by 260

  14. Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis

    Authors: , , , , , , , - Lung Cancer 2021 cited by 53

  15. Intraoperative Unfractionated Heparin Unresponsiveness during Endovascular Repair of a Ruptured Abdominal Aortic Aneurysm following Administration of Andexanet Alfa for the Reversal of Rivaroxaban

    Authors: , , , , , , - Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2019 cited by 40

  16. BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study

    Authors: , , , , , , , - Journal of Thrombosis and Haemostasis 2005 cited by 301

  17. Postdischarge thrombosis and hemorrhage in patients with COVID-19

    Authors: , , , , , , , - Blood 2020 cited by 256

  18. Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2003 cited by 809

  19. Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery

    Authors: , , , - New England Journal of Medicine 2001 cited by 661

  20. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.

    Authors: , , , , , , , - Circulation 1994 cited by 599

  21. Pros and cons of new oral anticoagulants

    Authors: - Hematology 2013 cited by 228

  22. Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH

    Authors: , , , , , - Journal of Thrombosis and Haemostasis 2012 cited by 134

  23. The plasma kallikrein–kinin system and risk of cardiovascular disease in men

    Authors: , , , , , , , , , - Journal of Thrombosis and Haemostasis 2007 cited by 112

  24. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank

    Authors: , , , , , , , , , , , - Blood 2024 cited by 24